MRC/BHF Heart Protection Study Of Cholesterol Lowering With Simvastatin In 20,536 High-Risk Individuals: A Randomised Placebo-Controlled Trial.

·2002·DOI
Health Sciences and Innovation
Health Sciences
Pharmacology and Toxicology
Cardiovascular Risk Factor Analysis

Role in the Field

Neutralin Health Sciences and Innovation
Neutralin Health Sciences
Neutralin Pharmacology and Toxicology
Neutralin Cardiovascular Risk Factor Analysis

Abstract

Citations

6,925

Year

2002

PageRank

5.4 / 10

Relative influence (log-scaled)

Related Papers

10 of 10 papers

Global Burden Of Cardiovascular Diseases And Risk Factors, 1990–2019
·2020·6,605 citations
Heart Disease And Stroke Statistics—2015 Update
·2015·6,190 citations
General Cardiovascular Risk Profile For Use In Primary Care
·2008·5,919 citations
Effect Of Potentially Modifiable Risk Factors Associated With Myocardial Infarction In 52 Countries (The INTERHEART Study): Case-Control Study.
·2004·8,883 citations
Markers Of Inflammation And Cardiovascular Disease
·2003·5,517 citations
Primary Prevention Of Cardiovascular Disease
·2002·7,486 citations
Prediction Of Coronary Heart Disease Using Risk Factor Categories
·1998·8,051 citations
Randomized Trial Of Estrogen Plus Progestin For Secondary Prevention Of Coronary Heart Disease In Postmenopausal Women
·1998·5,924 citations
The Effect Of Pravastatin On Coronary Events After Myocardial Infarction In Patients With Average Cholesterol Levels
·1996·7,406 citations
Randomised Trial Of Cholesterol Lowering In 4444 Patients With Coronary Heart Disease: The Scandinavian Simvastatin Survival Study (4S)
·1994·7,993 citations